⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Novo Nordisk initiates 2026 share repurchase programme
globenewswire.com
NVO
Novo Nordisk has published its annual report for 2025
globenewswire.com
NVO
Novo Nordisk's sales increased by 6% in Danish kroner and by 10% at constant exchange rates to DKK 309.1 billion in 2025
globenewswire.com
NVO
Novo Nordisk A/S: CagriSema demonstrated superior HbA1c reduction of 1.91%-points and weight loss of 14.2% in adults with type 2 diabetes in the REIMAGINE 2 trial
globenewswire.com
NVO
Smart Insulin Pens Market Driven by 11.34% CAGR and Rising Diabetes Prevalence
globenewswire.com
NVO
New employee representative on the Board of Directors of Novo Nordisk A/S
globenewswire.com
NVO
Hydrophobic Interaction Chromatography Research Report 2026 - Global $639.21 Mn Market Trends, Opportunities, and Forecasts to 2031
globenewswire.com
NVO
AZN
BetterWay Launches GLP-1 Blood Testing Panel at Retail Locations in Austin and Temple
accessnewswire.com
NVO
Ivonescimab Included in FirstWord Pharma's "The Drugs That Will Shape 2026"
prnewswire.com
AZN
NVS
MRNA
GILD
NVO
PFE
Elevate Health GLP-1 Program Analysis: Tirzepatide vs Semaglutide Access, Compounded Medication Pricing and Telehealth Prescription Pathways
accessnewswire.com
NVO
LLY